Skip to content

ASPIRE BIOPHARMA HOLDINGS, INC.: filings

Every ASPIRE BIOPHARMA HOLDINGS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 21 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-13fiscal Q2 202635980001493152-26-037819
10-Q2026-05-15fiscal Q1 202635690001493152-26-023802
10-K/A2026-04-08fiscal FY 202534610001493152-26-015737
10-K2026-03-30fiscal FY 202534610001493152-26-013682
10-Q/A2025-11-14fiscal Q3 202533930001493152-25-023619
10-Q2025-11-14fiscal Q3 202533930001493152-25-022595
10-Q2025-08-13fiscal Q2 202523620001641172-25-023573
10-Q/A2025-08-13fiscal Q1 202522470001641172-25-023566
10-Q2025-05-14fiscal Q1 202522470001641172-25-010316
10-K2025-04-07fiscal FY 202417340001641172-25-002917
10-Q2024-11-14fiscal Q3 202418540001493152-24-045850
10-Q2024-08-16fiscal Q2 202417480001493152-24-032815
10-Q2024-06-05fiscal Q1 202415310001493152-24-022728
10-K2024-03-11fiscal FY 202318340001493152-24-009602
10-Q2023-11-08fiscal Q3 202318530001493152-23-039795
10-Q2023-08-08fiscal Q2 202317480001410578-23-001594
10-Q2023-05-11fiscal Q1 202316330001410578-23-001031
10-K2023-03-21fiscal FY 202217300001410578-23-000316
10-Q2022-11-10fiscal Q3 202216450001410578-22-003172
10-Q2022-08-11fiscal Q2 202216410001410578-22-002287
10-Q2022-05-16fiscal Q1 202216300001410578-22-001691

Inspect the source

Entity
ASPIRE BIOPHARMA HOLDINGS, INC. / CIK 0001847345
Captured
2026-09-21T17:32:16.061Z
SEC response SHA-256
40d6d0e6731934d6542812e865819d815a2e8f7284c4e26de8ab491caca2a549

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001847345.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))